Skip to content
2000
Volume 23, Issue 4
  • ISSN: 1871-5303
  • E-ISSN: 2212-3873

Abstract

Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by damage to multiple systems and a higher risk of cardiovascular disease. In addition, several studies have found that insulin resistance (IR) is more prevalent in SLE patients than controls, increasing the risk of prediabetes, type 2 diabetes mellitus (T2DM) and morbidity. The objective of this review article was to summarize the most relevant evidence about the relationship among IR, T2DM and SLE, including the effects of proinflammatory states, acute-phase proteins, pro-inflammatory cytokines, and pharmacological SLE treatment. A better understanding of the mechanisms involved in these comorbidities will allow better treatment strategies.

Loading

Article metrics loading...

/content/journals/emiddt/10.2174/1871530322666220908154253
2023-04-01
2025-06-20
Loading full text...

Full text loading...

/content/journals/emiddt/10.2174/1871530322666220908154253
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test